Selinexor in Advanced Liposarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
71 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucl Saint-Luc
Brussels, Belgium
- Uz Brussel
Brussels, Belgium
- Uz Gent
Ghent, Belgium
- Cross Cancer Center - Alberta Health Services
Edmonton, Alberta, Canada
- the Ottawa Hospital Cancer
Ottawa, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- Mcgill University
Montreal, Quebec, Canada
- Institut Bergonie
Bordeaux, France
- Oscar Lambret Center
Lille, France
- Centre Leon Berard
Lyon, France
- Timone University Hospital
Marseille, France
- Institut Régional Du Cancer de Montpellier (icm)
Montpellier, France
- Clcc Antoine Lacassagne
Nice, France
- Institut Curie
Paris, France
- Institut Claudius Regaud
Toulouse, France
- Institut Gustave Roussy
Villejuif, France
- Helios Hospital Berlin-Buch
Berlin, Germany
- Technische Universitaet Dresden Med. Fakultaet Carl Gustav Carus Med. Klinik U. Poliklinik I
Dresden, Germany
- National Center for Tumor Diseases, Univeristy Hospital Heidelberg
Heidelberg, Germany
- University Hospital Mannheim
Mannheim, Germany
- Klinik Und Poliklinik Für Innere Medizin Iii, Hämatologie Und Onkologie Klinikum Rechts Der Isar Der Tu Muenchen
München, Germany
- Soroka University Medical Center
Beersheba, Israel
- Hadassah Medical Center
Jerusalem, Israel
- Rabin Medical Center
Petah Tikva, Israel
- Sheba Medical Center
Ramat Gan, Israel
- Tel Aviv Sourasky Medical
Tel Aviv, Israel
- Assaf Harofe Medical Center
Ẕerifin, Israel
- Candiolo Cancer Institute
Candiolo, Italy
- Istituto Nazionale Dei Tumori, Milan
Milan, Italy
- U.O.C. Oncologia Medica Oncology Department
Palermo, Italy
- Policlinico Universitario Campus Biomedico
Roma, Italy
- "germans Trias Pujol" University Hospital
Badalona, Spain
- Hospital Ico Bellvitge
Barcelona, Spain
- Hospital Sant Pau Barcelona
Barcelona, Spain
- Vall D´hebron University Hospital
Barcelona, Spain
- Hospital Universitario Clínico San Carlos
Madrid, Spain
- Hospital Universitario Virgen del Rocio
Seville, Spain
- Hospital la Fe Valencia
Valencia, Spain
- Sahlgrenska Universitetssjukhuset
Gothenburg, Sweden
- Skane University Hospital
Lund, Sweden
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jan 2016
- Primary completion
- 28 Oct 2020
- Completion
- 26 Oct 2021
- Last update posted
- 23 Jan 2023
- Registered enrollment
- 342
- Registry id
- NCT02606461
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.